Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effectiveness of Microdosed GLP-1 in Improving Health, Quality of Life, and Longevity Measures
Sponsor: AgelessRx
Summary
The goal of this clinical study has two objectives. The Primary Objective is to evaluate the effectiveness of microdosed GLP-1 receptor agonists in improving measures of health, quality of life, and longevity. The Secondary Objective: To assess the impact of these therapies on weight management practices and metabolic health.
Official title: Effectiveness of Microdosed GLP-1 in Improving Health, Quality of Life, and Longevity Measures: For Use in Healthy Individuals Ages 18-65 Who Seek to Improve Their Health and Longevity Through Low-dose (Microdosed) GLP1 Receptor Agonists
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
150
Start Date
2024-11-01
Completion Date
2025-12-01
Last Updated
2025-07-30
Healthy Volunteers
Yes
Conditions
Interventions
GLP-1
Sublingual GLP1 (weekly), Subcutaneous GLP1 (weekly), Sublingual Placebo (weekly) for up to 6 months.
Placebo
Sublingual Placebo (weekly) for up to 6 months
Locations (1)
AgelessRx
Ann Arbor, Michigan, United States